COMMUNIQUÉS West-GlobeNewswire

Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019
01/04/2019
CD137 and PD-L1 bispecific antibody with context-dependent T cell activation UTRECHT, Netherlands, April 01, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage [...]
Replimune Announces Presentation at the American Association for Cancer Research Annual Meeting 2019
01/04/2019
WOBURN, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced that pre- [...]
Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer
01/04/2019
CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Tetra Bio-Pharma Announces Employment Contract Renewal of CEO Guy Chamberland
01/04/2019
OTTAWA, April 01, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), today announced that the Company has renewed its CEO Guy Chamberland’s employment agreement. “ [...]
Tetra Bio-Pharma annonce le renouvellement du contrat de travail du chef de la direction Guy Chamberland
01/04/2019
OTTAWA, 01 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra » ou la « Société ») (TSX-V : TBP) (OTCQB : TBPMF), a annoncé aujourd’hui que la Société a renouvelé le contrat de travail de son chef de la [...]
Study Confirms Tesamorelin Significantly Reduces Liver Fat in HIV Patients With NAFLD
01/04/2019
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that top-line results, from a study funded by the National Institutes of Health led by Dr. Steve [...]
Une étude confirme que la tésamoréline réduit significativement le gras hépatique chez les patients séropositifs atteints de stéatose hépatique non alcoolique
01/04/2019
MONTREAL, 01 avr. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) a annoncé aujourd’hui que les premiers résultats issus d’une étude financée par le National Institutes of Health (NIH), [...]
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
01/04/2019
ZUG, Switzerland and CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/04/2019
DUBLIN, Ireland, April 01, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today [...]
BioCryst to Present at Upcoming Investor Conferences
01/04/2019
RESEARCH TRIANGLE PARK, N.C., April 01, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the H.C. Wainwright Global Life Sciences Conference in [...]
Emerald’s Pure Sunfarms Joint Venture Acquires Second 1.1 Million Square Foot Greenhouse, Doubling Potential Production Capacity to 150,000 Kilograms
01/04/2019
Emerald extends and expands supply agreement to purchase 25% of Pure Sunfarms’ aggregate cannabis production VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald [...]
Algernon Pharmaceuticals Announces Reduction of Key Secondary Marker of Fibrosis in Pre-Clinical NASH Study
01/04/2019
VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development [...]
Cyclacel Announces Presentation of Phase 1 Data of Sapacitabine Regimen in Patients With BRCA Mutant Breast Cancer at AACR 2019
01/04/2019
-- Clinical benefit in PARP inhibitor-naïve patients supports ongoing Phase 1b/2 IST study of sapacitabine and olaparib combination in BRCA mutant breast cancer -- BERKELEY HEIGHTS, N.J., April 01, 2019 (GLOBE NEWSWIRE [...]
Ziopharm Oncology Announces FDA Fast Track Designation for Ad-RTS-hIL-12 plus Veledimex for the Treatment of Recurrent Glioblastoma
01/04/2019
BOSTON, April 01, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP), a clinical stage immuno-oncology company developing next generation cell and gene therapies, today announced that the U.S. Food and [...]
Retail Cannabis Officially Hits Ontario Today Through Hobo Recreational Cannabis Store
01/04/2019
One of only three retail locations slated for Ottawa, Hobo’s launch comes on the heels of the province’s new cannabis retail model OTTAWA, April 01, 2019 (GLOBE NEWSWIRE) -- Hobo Recreational Cannabis Store (“ Hobo ”), [...]
Merus et Incyte présentent les données précliniques du programme MCLA-145 lors du congrès annuel 2019 de l'AACR
01/04/2019
Anticorps bispécifique CD137 et PD-L1 avec activation des lymphocytes T dépendante du contexte UTRECHT, Pays-Bas, 01 avr. 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (« Merus », « nous », « notre », « nos » ou [...]
Exactus Appoints Troy Rhonemus to Advisory Board
01/04/2019
Troy Rhonemus will Join Emiliano Aloi, President and Advisory Board Member, to Guide the Company on the Path to Setting Industry Standards on Regulatory Strategy and Farming Techniques DELRAY BEACH, Fla., April 01, 2019 [...]
HEXO completes first harvest in its 1 million sq. ft. greenhouse
01/04/2019
GATINEAU, Quebec, April 01, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (TSX: HEXO ; NYSE-A: HEXO ) (“HEXO” or the "Company") has completed the first harvest in its 1 million sq. ft. expansion, marking an important execution [...]
HEXO effectue sa première récolte dans sa serre d’un million de pieds carrés
01/04/2019
GATINEAU, Québec, 01 avr. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (TSX: HEXO ; NYSE-A: HEXO ) (« HEXO » ou la « Société ») a effectué la première récolte dans sa serre agrandie d’un million de pieds carrés, marquant ainsi [...]

Pages